ICON plc, (ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PMG Research, Inc., ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME ...
Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...
Clinical research organization ICON plc (NASDAQ:ICLR) announced its financial guidance for fiscal year 2025 on Tuesday. What Happened: The Dublin-based company forecasts revenues of $8.05 billion — $8 ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government ...
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today ...
Irish contract research organisation (CRO) ICON has added global heft to its US-based staffing business by acquiring DOCS International, a European clinical research staffing organisation based in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results